Results 111 to 120 of about 3,073 (165)

Characterization of Cell-Surface Interactions of Ligands Using ¹⁹F NMR and DNP Hyperpolarization. [PDF]

Anal Chem
Qi C, Pradhan N, Hilty C.
europepmc   +1 more source

Analyses d\u27ouvrages et d\u27articles français et étrangers [PDF]

core  

A Prospective Comparison of Azilsartan and Amlodipine for Bevacizumab-induced Hypertension and Proteinuria in Colorectal Cancer. [PDF]

In Vivo
Nihei S, Ujiie H, Saito K, Ikeda T, Asaka J, Yaegashi M, Asahi K, Kudo K.   +7 more
europepmc   +1 more source

β-Lactam Ylidenes: An Overlooked Class of N-Heterocyclic Carbenes. [PDF]

Chemistry
Karl L, Deißenbeck D, Meisner J, Ganter C.   +3 more
europepmc   +1 more source

1,3,4-oxadiazoles as inhibitors of the atypical member of the BET family bromodomain factor 3 from Trypanosoma cruzi (TcBDF3). [PDF]

Front Microbiol
Alonso VL, Escalante AM, Rodríguez Araya E, Frattini G, Tavernelli LE, Moreno DM, Furlan RLE, Serra E.   +7 more
europepmc   +1 more source

2:1 Adducts Arising from Reactions between Benzynes and 1,3,4-Oxadiazoles. [PDF]

Org Lett
Guzman AL, Kevorkian PV, Hoye TR.
europepmc   +1 more source

A two-decade overview of oxadiazole derivatives as promising anticancer agents. [PDF]

RSC Adv
Salem M, El-Adl K, El-Morsy A, Abulkhair HS.   +3 more
europepmc   +1 more source

Bridging mechanism and design: modern medicinal chemistry approaches to thymidylate synthase inhibitors. [PDF]

RSC Adv
Al-Karmalawy AA, Eissa ME, Yousef TA, Al Khatib AO, Hawas SS.   +4 more
europepmc   +1 more source

Bis-Oxadiazole Assemblies as NO-Releasing Anticancer Agents. [PDF]

Pharmaceutics
Matnurov EM, Stebletsova IA, Larin AA, Arakelyan J, Ananyev IV, Gushchin AL, Fershtat LL, Babak MV.   +7 more
europepmc   +1 more source

Recent Advances: Heterocycles in Drugs and Drug Discovery. [PDF]

Int J Mol Sci
Pibiri I.
europepmc   +1 more source